World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
14708
World Ranking
2257
National Ranking
1091

Medicine

D-Index
72
Citations
14710
World Ranking
19904
National Ranking
9912

Christopher L. King publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Christopher L. King sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 236 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Christopher L. King D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher L. King sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Christopher L. King is affiliated with Case Western Reserve University in the United States and has contributed extensively to the field of Medicine, with a primary focus on Infectious Diseases. Their research spans several subfields including Public Health, Environmental and Occupational Health, Parasitology, and aspects of Health, Toxicology and Mutagenesis.

Their publication record includes over 155 works, with 81 concentrating on Infectious Diseases, reflecting a strong focus on diseases affecting global health. King's research topics frequently cover areas such as SARS-CoV-2 and COVID-19 research, parasitic diseases research and treatment, and malaria research and control. Other notable topics include parasites and host interactions, mosquito-borne diseases and control, vaccine coverage and hesitancy, and COVID-19 clinical research studies.

Frequent coauthors in King's research collaborations include:

  • David H. Canaday
  • Brigid Wilson
  • Oladayo A. Oyebanji
  • Alejandro B. Balazs
  • Stefan Gravenstein

King has published regularly in a range of scientific venues, with multiple articles appearing in:

  • PLoS Neglected Tropical Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Tropical Medicine and Hygiene
  • Malaria Journal
  • Clinical Infectious Diseases

Selected recent papers demonstrate a strong emphasis on both COVID-19 and parasitic disease research:

  • "Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents," 2021, Clinical Infectious Diseases
  • "Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies," 2021, Journal of Extracellular Vesicles
  • "Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection," 2023, Nature Communications
  • "Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunity," 2020, Nature Communications
  • "COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents," 2022, EBioMedicine

Best Publications

  • Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people

    Didier Ménard;Céline Barnadas;Christiane Bouchier;Cara Henry-Halldin

  • Challenges in infant immunity: implications for responses to infection and vaccines

    Mercy Prabhudas;Becky Adkins;Hayley Gans;Christopher King

  • Cytokine control of parasite-specific anergy in human lymphatic filariasis Preferential induction of a regulatory T helper type 2 lymphocyte subset

    Christopher L. King;Siddhartha Mahanty;V. Kumaraswami;John S. Abrams

  • Helminth- and Bacillus Calmette-Guérin-Induced Immunity in Children Sensitized In Utero to Filariasis and Schistosomiasis

    Indu Malhotra;Peter Mungai;Alex Wamachi;John Kioko

  • Evidence that Systemic Gentamicin Suppresses Premature Stop Mutations in Patients with Cystic Fibrosis

    J. P. Clancy;Zsuzsa Bebök;Fadel Ruiz;Chris King

  • Immunoglobulin G Subclass-Specific Responses against Plasmodium falciparum Merozoite Antigens Are Associated with Control of Parasitemia and Protection from Symptomatic Illness

    Danielle I. Stanisic;Jack S. Richards;Jack S. Richards;Fiona J. McCallum;Fiona J. McCallum;Pascal Michon

  • Identification and Prioritization of Merozoite Antigens as Targets of Protective Human Immunity to Plasmodium falciparum Malaria for Vaccine and Biomarker Development

    Jack Richards;Thangavelu U Arumugam;Linda Reiling;Julie Healer

  • Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity.

    Christopher L. King;Ahmed Medhat;Indu Malhotra;Mohamed Nafeh

  • Evidence That Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein-1 (MSP-119) Can Play a Protective Role against Blood-Stage Plasmodium falciparum Infection in Individuals in a Malaria Endemic Area of Africa

    Chandy C. John;Rebecca A. O'Donnell;Peter Odada Sumba;Ann M. Moormann

  • Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein

    Brian T Grimberg;Rachanee Udomsangpetch;Jia Xainli;Amy McHenry

  • Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis

    Edward K. Thomsen;Edward K. Thomsen;Nelly Sanuku;Manasseh Baea;Samson Satofan

  • The risk of malarial infections and disease in Papua New Guinean children.

    Pascal Michon;Jennifer L. Cole-Tobian;Elijah Dabod;Sonja Schoepflin

  • A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.

    Christopher L King;James Suamani;Nelly Sanuku;Yao-Chieh Cheng

  • Regulation of the immune response in lymphatic filariasis and onchocerciasis

    Christopher L. King;Thomas B. Nutman

  • Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection

    Christopher L. King;Pascal Michon;Ahmad Rushdi Shakri;Alexandra Marcotty

  • In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults.

    Indu Malhotra;John Ouma;Alex Wamachi;John Kioko

  • Can prenatal malaria exposure produce an immune tolerant phenotype?: A prospective birth cohort study in Kenya

    Indu Malhotra;Arlene Elizabeth Dent;Peter Mungai;Alex Wamachi

  • Acquisition of Antibodies against Plasmodium falciparum Merozoites and Malaria Immunity in Young Children and the Influence of Age, Force of Infection, and Magnitude of Response

    Danielle I. Stanisic;Freya J. I. Fowkes;Melanie Koinari;Sarah Javati

  • Do antenatal parasite infections devalue childhood vaccination

    A. Desiree LaBeaud;A. Desiree LaBeaud;Indu Malhotra;Maria J. King;Christopher L. King

  • Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria.

    Christopher L. King;John H. Adams;Jia Xianli;Brian T. Grimberg

  • B Cell Sensitization to Helminthic Infection Develops In Utero in Humans

    Christopher L. King;Indu Malhotra;Peter Mungai;Alex Wamachi

Frequent Co-Authors

Ivo Mueller
Ivo Mueller Walter and Eliza Hall Institute of Medical Research
James W. Kazura
James W. Kazura Case Western Reserve University
James G. Beeson
James G. Beeson Burnet Institute
John H. Adams
John H. Adams University of South Florida
Peter Siba
Peter Siba Papua New Guinea Institute of Medical Research
Peter A. Zimmerman
Peter A. Zimmerman Case Western Reserve University
Eric M. Muchiri
Eric M. Muchiri Case Western Reserve University
Thomas B. Nutman
Thomas B. Nutman National Institute of Allergy and Infectious Diseases
Freya J. I. Fowkes
Freya J. I. Fowkes Burnet Institute
Chetan E. Chitnis
Chetan E. Chitnis Institut Pasteur

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many students transition into nursing roles to apply immunological knowledge in clinical settings. Programs like acute care nurse practitioner programs provide specialized training for advanced practice nurses managing complex patient cases, often involving immune system disorders.

If you’re looking for a faster route to becoming a nurse practitioner, consider accelerated NP programs. These programs are designed for individuals with a previous degree, helping to fast-track their nursing careers with focused clinical skills and advanced immunological concepts.

For those without a nursing background, online RN programs for non nurses offer flexible options to enter the nursing field. These programs integrate fundamental science with clinical training, ideal for understanding immune responses within patient care.

Additionally, easiest accelerated nursing programs can be great stepping stones for students seeking a quicker admission process and expedited entry into the nursing profession, supporting a swift transition into immunology-related healthcare roles.

Best Scientists Citing Christopher L. King

Trending Scientists

Recently Published Articles